Koo Jakap
SEC insider (Form 3/4/5 filer). CIK 0002041972. Director at Apimeds Pharmaceuticals US, Inc. (APUS). 4 reported Form 4/5 transactions since Sep 2024; latest on Nov 11, 2025. Located in HOPEWELL, NJ.
Companies Koo Jakap has filed insider reports for
- Apimeds Pharmaceuticals US, Inc. (APUS): Director
Koo Jakap
CIK: 0002041972
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apimeds Pharmaceuticals US, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Nov 11, 2025APUS
Apimeds Pharmaceuticals US, Inc.
AwardDirectStock Option (right to buy)
10K shares- - Oct 15, 2025APUS
Apimeds Pharmaceuticals US, Inc.
AwardDirectStock Option (right to buy)
3K shares- - May 16, 2025APUS
Apimeds Pharmaceuticals US, Inc.
AwardDirectStock Option (right to buy)
5.8K shares- - May 12, 2025APUS
Apimeds Pharmaceuticals US, Inc.
PurchaseDirect28.5K shares at avg. $1.99$57K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 11, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| Oct 15, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | Award Stock Option (right to buy) | 3,000 | - | - | Direct |
| May 16, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | Award Stock Option (right to buy) | 5,780 | - | - | Direct |
| May 12, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | Purchase | 28,500 | $1.99 | $56,715 | Direct |
1-4 of 4 transactions